<DOC>
	<DOCNO>NCT00516958</DOCNO>
	<brief_summary>To compare rate clinical success Topical Dermacyn™ v . Oral Levofloxacin v . Combined therapy , subject mild diabetic foot infection non-ischemic ulcer .</brief_summary>
	<brief_title>Pilot Study Safety Clinical Efficacy Topical Dermacyn™ Wound Care Treat Mild Diabetic Foot Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Sodium Hypochlorite</mesh_term>
	<criteria>A patient must meet follow inclusion criterion enrol study : 1 . Males females &gt; 18 year age diabetes mellitus ( type 1 type 2 , control ) . 2 . Presence infect , nonischemic diabetic foot ulcer involve skin deep soft tissue stratify IDSA guideline UTC / 1B . 3 . Foot infection anticipate cured 10 day oral antibiotic therapy . 4 . Foot ulcer locate plantar , dorsal malleolar area . 5 . Ulcers 1 9 cm2 size . 6 . An accessible infection site culture . 7 . ABI Doppler ≥ 0.8 TcPO2 ≥ 30 mmHg . 8 . Palpable pulse study foot ( either dorsalis posterior tibial artery ) . 9 . Willing able give inform consent . 10 . Willing comply requirement participation study . Patients exclude meet follow criterion time randomization : 1 . Previous antibiotic treatment receive 24 hour within 72 hour study . 2 . Necrotizing fasciitis , deep abscess soft tissue , sinus tract , gas gangrene , infect burn . 3 . Superinfected eczema chronic inflammatory skin condition ( i.e. , atopic dermatitis ) . 4 . The patient´s ulcer locate stump amputate extremity . 5 . The patient 's ulcer due nondiabetic etiology . 6 . Infections complicate presence prosthetic material . 7 . Osteomyelitis 8 . Females childbearing potential unable take adequate contraceptive precaution breastfeed . 9 . Known liver disease , total bilirubin &gt; 5 time Upper Limit Normal ( ULN ) ; know neutropenia ( absolute neutrophil count &lt; 500 cells/mm3 ) . 10 . Hypersensitivity chlorine quinolones . 11 . Need additional concomitant systemic antibacterial agent study drug ( ) . 12 . Concomitant glucocorticoid dos ( &gt; 5mg prednisone day equivalent ) . 13 . Adjuvant therapy hyperbaric oxygen topical formulation contain growth factor , antimicrobial enzymatic debriders . 14 . A history diseases immune function ( HIV , chronic granulomatous disease ) . 15 . Any medical condition , investigator´s opinion , require dose modification Levofloxacin le 750 mg day . 16 . Has receive investigational agent ≤1 month prior baseline evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>diabetic</keyword>
	<keyword>ulcer</keyword>
	<keyword>infection</keyword>
	<keyword>topical</keyword>
	<keyword>wound</keyword>
</DOC>